What is DocGo's common stock, shares authorized (in shares)?

DocGo (DCGO) reported common stock, shares authorized (in shares) of $500M in Q1 2026.

How has DocGo's common stock, shares authorized (in shares) changed year-over-year?

DocGo's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.

What is the long-term trend for DocGo's common stock, shares authorized (in shares)?

Over 5 years (2020 to 2025), DocGo's common stock, shares authorized (in shares) has grown at a 31.8% compound annual growth rate (CAGR), from $125.48M to $500M.

DocGo DCGO Common stock, shares authorized (in shares)

Common stock, shares authorized (in shares) at other companies

CVS HealthCVS

——

Option Care Health, Inc.OPCH

——

Teladoc HealthTDOC

——

InfuSystem HoldingsINFU

——

Nutex Health Inc.NUTX

——

SRT

Strata Critical Medical, Inc. Class A Common StockSRTA

——

Other financials

Income statement

See full

Revenue$75.6M-21.3%

Gross profit-$407.9M-25.6%

Operating income-$18.7M-33.7%

Net income-$14.8M-57.0%

EPS (diluted)-$0.15-66.7%

Balance sheet

See full

Cash & equivalents$46.8M-54.6%

Total debt$28.5M-7.6%

Total equity$132.3M-57.2%

Total assets$209.2M-51.4%

Cash flow

See full

Operating cash flow-$4.7M-151%

CapEx$430.3K-58.2%

Free cash flow-$5.1M-162%

Valuation

See full

Market cap$50.98M-67.2%

Enterprise value$32.67M-59.1%

P/S0.2×-0.2×

Profitability

See full

Operating margin-60.6%—

Net margin-62.2%—

FCF margin14.6%+8.1pp

Returns & leverage

See full

Return on equity-85%—

Debt / equity0.2×+0.1×

Current ratio1.8×-0.7×

Where this comes from

Reported directly by DocGo in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: DocGo’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about DocGo's common stock, shares authorized (in shares).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is DocGo's common stock, shares authorized (in shares)?: DocGo (DCGO) reported common stock, shares authorized (in shares) of $500M in Q1 2026.
How has DocGo's common stock, shares authorized (in shares) changed year-over-year?: DocGo's common stock, shares authorized (in shares) decreased by 0.0% year-over-year, from $500M to $500M.
What is the long-term trend for DocGo's common stock, shares authorized (in shares)?: Over 5 years (2020 to 2025), DocGo's common stock, shares authorized (in shares) has grown at a 31.8% compound annual growth rate (CAGR), from $125.48M to $500M.